Product Information

CLOPIDOGREL 75 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0470 per EA under NDC 82009002105. Its NADAC has been published 190 times since Jan 4, 2023.

FDA first approved this application on Jan 14, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLOPIDOGREL 75 MG TABLET

Clopidogrel bisulfate
$0.0470per EA

Strength

75 mg/1

NDC

82009002105

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CLOPIDOGREL BISULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076273

FDA Approved

1/14/2008

TE Code

AB

On Market Since

11/15/2022

Pharmacological Classes

Cytochrome P450 2C8 Inhibitors
Decreased Platelet Aggregation
P2Y12 Platelet Inhibitor
P2Y12 Receptor Antagonists

Price Statistics

The NADAC for CLOPIDOGREL 75 MG TABLET has been published 190 times since Jan 4, 2023, and over the history we have for it it has declined 21.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0470 per EA
All-time high$0.0652 (Feb 14, 2024)
All-time low$0.0469 (Jul 22, 2026)
52-week high$0.0584
52-week low$0.0469
Median price$0.0599
Average price$0.0586
Largest weekly change-18.5% (Nov 20, 2024)
Weeks tracked190
Tracking sinceJan 4, 2023

Price History

1W

+0.3%

1M

+0.3%

3M

-2.6%

6M

-6.0%

1Y

-19.5%

3Y

-26.3%

5Y

N/A

All

-21.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CLOPIDOGREL 75 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLOPIDOGREL 75 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0470 per EA (NDC 82009002105), effective Aug 19, 2026.

How has the price of CLOPIDOGREL 75 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLOPIDOGREL 75 MG TABLET has declined 21.3%. It has been tracked across 190 weekly CMS publications since Jan 4, 2023.

What are the highest and lowest recorded NADAC prices for CLOPIDOGREL 75 MG TABLET?

Since Jan 4, 2023, the NADAC for CLOPIDOGREL 75 MG TABLET has ranged from a low of $0.0469 (Jul 22, 2026) to a high of $0.0652 (Feb 14, 2024), with a median of $0.0599 per EA.

Are there cheaper alternatives to CLOPIDOGREL 75 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOPIDOGREL 75 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLOPIDOGREL 75 MG TABLET?

CLOPIDOGREL 75 MG TABLET (NDC 82009002105) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.